Publications scientifiques

Work Package 1

2023

• Metivier, L., et al. "Impact of adapted physical activity on hippocampal N-Acetyl Aspartate in patients with schizophrenia." European Psychiatry 66.S1 (2023): S447-S447.
• Dollfus, S., et al. "Self-assessment of auditory verbal hallucinations in schizophrenia; validation of a digital device." European Psychiatry 66.S1 (2023): S490-S490.
• Pre-print : Blackburn, Patrick R., et al. "Loss-of-function variants in CUL3 cause a syndromic neurodevelopmental disorder." medRxiv (2023): 2023-06.
• Wagner, Elias, et al. "Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group." Schizophrenia Bulletin (2023): sbad030.
• Fovet, Thomas, et al. "Opening the black box of hospitalizations in French high-secure psychiatric forensic units." L'encephale (2023).
• Lahogue, Caroline, et al. "5-HT6 Receptors Sex-Dependently Modulate Hippocampal Synaptic Activity through GABA Inhibition." Biomolecules 13.5 (2023): 751.
• Bouaziz, Noomane, et al. "Real world transcranial magnetic stimulation for major depression: A multisite, naturalistic, retrospective study." Journal of Affective Disorders 326 (2023): 26-35.
• Batail, Jean-Marie, et al. "No place in France for repetitive transcranial magnetic stimulation in the therapeutic armamentarium of treatment-resistant depression?" Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation 16.3 (2023): 927-929.
• Porpiglia, Federica, et al. "Anti-leucine-rich glioma-inactivated 1 encephalitis revealed by a manic episode: insights from frontal lobe dysfunction in neuropsychiatry through neuropsychology and metabolic imaging. A case report." Frontiers in Psychiatry 14 (2023): 1168302.
• Rothärmel, Maud, et al. "The priming effect of repetitive transcranial magnetic stimulation on clinical response to electroconvulsive therapy in treatment-resistant depression: a randomized, double-blind, sham-controlled study." Psychological Medicine 53.5 (2023): 2060-2071.
• Montvidas, Jonas, et al. "Correlation of Health-Related Quality of Life with Negative Symptoms Assessed with the Self-Evaluation of Negative Symptoms Scale (SNS) and Cognitive Deficits in Schizophrenia: A Cross-Sectional Study in Routine Psychiatric Care." Journal of Clinical Medicine 12.3 (2023): 901.

2022

• Brunelin, Jerome, et al. "Safety of" accelerated" rTMS protocols with twice-daily sessions in patients with schizophrenia-A comment on Caulfield et al." Journal of psychiatric research 156 (2022): 754-757.
• Samalin, Ludovic, et al. "Esketamine nasal spray in patients with treatment-resistant depression: the real-world experience in the French cohort early-access programme." International Journal of Psychiatry in Clinical Practice 26.4 (2022): 352-362.
• Levy, Michael A., et al. "Functional correlation of genome‐wide DNA methylation profiles in genetic neurodevelopmental disorders." Human mutation 43.11 (2022): 1609-1628.
• Liu, Dongjing, et al. "Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations." Nature genetics 55.3 (2023): 369-376.
• Trubetskoy, Vassily, et al. "Mapping genomic loci implicates genes and synaptic biology in schizophrenia." Nature 604.7906 (2022): 502-508.
• Laurin, Andrew, et al. "Efficacy and safety of transcranial electric stimulation during the perinatal period: a systematic literature review and three case reports." Journal of Clinical Medicine 11.14 (2022): 4048.
• Chastan, Nathalie, et al. "Repetitive transcranial magnetic stimulation for patients with functional paralysis: a randomized controlled study." European Journal of Neurology 29.5 (2022): 1293-1302.
• Rothärmel, Maud, et al. "Efficacy and Safety of Intranasal Esketamine in Patients With Treatment-Resistant Depression and Comorbid Chronic Post-traumatic Stress Disorder: Open-Label Single-Arm Pilot Study." Frontiers in Psychiatry 13 (2022): 865466.
• Moulier, Virginie, et al. "A retrospective study of postictal suppression during electroconvulsive therapy." Journal of Clinical Medicine 11.5 (2022): 1440.
• Dollfus, Sonia, et al. "European validation of the self-evaluation of negative symptoms (SNS): a large multinational and multicenter study." Frontiers in psychiatry 13 (2022): 826465.

2021

• Brunelin, Jerome, et al. "Examining transcranial random noise stimulation as an add-on treatment for persistent symptoms in schizophrenia (STIM’Zo): a study protocol for a multicentre, double-blind, randomized sham-controlled clinical trial." Trials 22 (2021): 1-21.
• Mazhari, Shahrzad, et al. "Validity and reliability of a Persian version of the self-evaluation of negative symptoms (SNS)." BMC psychiatry 21.1 (2021): 1-5.
• Tréhout, Maxime, et al. "A web-based adapted physical activity program (e-APA) versus health education program (e-HE) in patients with schizophrenia and healthy volunteers: study protocol for a randomized controlled trial (PEPSY V@ Si)." European Archives of Psychiatry and Clinical Neuroscience 271 (2021): 325-337.
• Vandevelde, A., et al. "Common mechanisms involved in manic switch and pain relief induced by lamotrigine: A case report and a literature review." L'encephale 47.3 (2021): 235-237.
• Moulier, Virginie, et al. "A prospective multicenter assessor-blinded randomized controlled study to compare the efficacy of short versus long protocols of electroconvulsive therapy as an augmentation strategy to clozapine in patients with ultra-resistant schizophrenia (SURECT study)." Trials 22 (2021): 1-15.
• Dobre, Daniela, et al. "Clinical features and outcomes of COVID-19 patients hospitalized for psychiatric disorders: a French multi-centered prospective observational study." Psychological Medicine 53.2 (2023): 342-350.
• Galderisi, S., et al. "EPA guidance on treatment of negative symptoms in schizophrenia." European Psychiatry 64.1 (2021): e21.
• Bouet, Valentine, et al. "A new 3-hit mouse model of schizophrenia built on genetic, early and late factors." Schizophrenia Research 228 (2021): 519-528.
• Jaussaud, C., et al. "Imputabilité des traitements anticholinergiques dans l’exacerbation d’épisodes psychotiques: à propos d’un cas de surdosage en tropatépine." La Revue de Médecine Interne 42.2 (2021): 127-130.
• Vandevelde, Anaïs, and Sonia Dollfus. "Early detection of schizophrenia, why and who to contact?" La Revue du Praticien 71.1 (2021): 36-41.

2020

• Montvidas, Jonas, et al. "Validation of the lithuanian version of the self-evaluation of negative symptoms scale (SNS)." Nordic journal of psychiatry 75.5 (2021): 351-355.
• Vandevelde, Anaïs, Lucie Métivier, and Sonia Dollfus. "Impact cérébral structurel et fonctionnel de la Clozapine chez les patients souffrant de schizophrénie: revue systématique des études longitudinales en neuroimagerie." The Canadian Journal of Psychiatry 66.8 (2021): 683-700.
• Husson, Thomas, et al. "Rare genetic susceptibility variants assessment in autism spectrum disorder: detection rate and practical use." Translational Psychiatry 10.1 (2020): 77.
• Chilton, Ilana, et al. "De novo heterozygous missense and loss‐of‐function variants in CDC42BPB are associated with a neurodevelopmental phenotype." American Journal of Medical Genetics Part A 182.5 (2020): 962-973.